Package 70436-010-02

{"route": ["ORAL"], "spl_id": "1b0d6505-54e6-a28f-e063-6294a90aae71", "openfda": {"upc": ["0370436010042", "0370436011049", "0370436011063", "0370436010066"], "unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993557"], "spl_set_id": ["06d4d890-11ed-4f31-8778-c73432e3ea69"], "manufacturer_name": ["Slate Run Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70436-010-02)", "package_ndc": "70436-010-02", "marketing_start_date": "20181201"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70436-010-04)", "package_ndc": "70436-010-04", "marketing_start_date": "20181201"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70436-010-06)", "package_ndc": "70436-010-06", "marketing_start_date": "20181201"}], "brand_name": "Bupropion Hydrochloride XL", "product_id": "70436-010_1b0d6505-54e6-a28f-e063-6294a90aae71", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "70436-010", "generic_name": "bupropion hydrochloride", "labeler_name": "Slate Run Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "XL", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA210015", "marketing_category": "ANDA", "marketing_start_date": "20181201", "listing_expiration_date": "20261231"}